Public Announcement

Buyback at over 10% premiumCorporate Actions View source PDF Explain this filing

ZYDUSLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹1040.30

prior close

₹1034.40

announcement price

In-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.0%-0.4% vs market

Pharmaceuticals peers, median of 160sector+0.2%-0.5% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty 100 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.4

15m

+0.3

30m

+0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.3+0.0-0.4+0.2-0.5

Next day

-0.2+0.3-0.5+0.2-0.3

+3.0+1.7+1.3+1.4+1.5

+3.5+1.3+2.2+1.3+2.2

+4.5+1.5+2.9+1.6+2.9

+4.0+0.1+3.9+1.0+3.0

+3.8-0.4+4.2+0.2+3.6

15d

+6.0+0.0+6.0+0.5+5.6

+4.4+2.5+1.8+2.8+1.5

+10.2+2.7+7.4+6.9+3.2

+7.7+3.3+4.4+8.2-0.5

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zydus Lifesciences Limited has announced a buyback of up to 95,65,217 equity shares (0.95% of paid-up capital) at INR 1,150 per share for a total amount not exceeding INR 1,100 crore. The buyback price represents a 23.88% premium over the volume weighted average price on NSE and a 26.14% premium over the 3-month average price. The tender offer will open from June 4, 2026 to June 10, 2026, with May 29, 2026 as the record date. The company states this is to distribute surplus cash to shareholders, optimize returns, and enhance shareholder value. The promoter group holds approximately 75.46% stake and may participate in the buyback.

Likely market impact

The significant premium (23-26%) offered signals management confidence in the company's intrinsic value. Shareholders who tender will receive a 23-26% premium over recent market prices, which could provide near-term support to the stock price.